Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
The company will participate in IR sessions sponsored by Nomura Securities and BofA for major overseas institutional investors. Key discussion topics via group meetings and conference calls include a review of Q2 2024 performance, earnings outlook for H2, continued rise in AI chip demand, and potential new demand for TC Bonders driven by HBM B2C market expansion.
📊 [Key Disclosure Contents & Summary of Major Figures]
- Date & Location: August 22, 2024 / Location: Not specified (
-) - Target Audience: Major Overseas Institutional Investors
- Purpose:
- Participation in Nomura Securities ‘Tech Tour’
- Participation in BofA ‘Virtual Tech Tour’
- Format: Group Meetings, Conference Call
- Sponsoring Institutions: Nomura Securities, BofA
- Key Presentation Content (Summary):
- Review of Q2 2024 performance and earnings outlook for H2
- Continuous rise in AI chip (GPU, HBM) demand
- Potential creation of new demand for TC Bonders following HBM expansion into the B2C market
- Board Resolution/Decision Date: August 21, 2024
- IR Materials: Date and URL not specified
- Other Material Details: Event schedule subject to change based on company circumstances
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 IR Event Execution and Material Verification
This filing serves as a notice announcing the schedule and key discussion topics for an upcoming IR event aimed at major overseas institutional investors. Tracking whether the session is conducted as scheduled on August 22, 2024, and whether any summary presentation materials are subsequently published is important to evaluate disclosed financial reviews and market outlooks. Relevant updates can be verified through subsequent official corporate filings or regular business reports (quarterly, half-year, annual).
📢 Legal Disclaimer & Source Notice
Source: This content was structured and newly generated based on official filing data from the Financial Supervisory Service DART system.
Investment Risk Warning: This content is provided strictly for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
